{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Enhanced+intervention&page=12", "query": { "intervention": "Enhanced intervention", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 3175, "total_pages": 318, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Enhanced+intervention&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Enhanced+intervention&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T18:04:52.333Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00024570", "title": "Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Malignant Glioma", "Glioblastoma Multiforme", "Anaplastic Astrocytoma", "Mixed Oligoastrocytoma" ], "interventions": [ { "name": "IL13-PE38QQR", "type": "DRUG" }, { "name": "targeted fusion protein therapy", "type": "PROCEDURE" }, { "name": "surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "INSYS Therapeutics Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2000-11", "completion_date": "2007-07", "has_results": false, "last_update_posted_date": "2014-11-14", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Tampa, Florida • Atlanta, Georgia + 5 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00024570" }, { "nct_id": "NCT07457970", "title": "Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Blood Pressure Monitoring", "Hypertension (HTN)", "Pregnancy" ], "interventions": [ { "name": "Enhanced Care Group", "type": "BEHAVIORAL" }, { "name": "Remote Blood Pressure Monitoring alone", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of South Carolina", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 240, "start_date": "2026-04-24", "completion_date": "2029-07-15", "has_results": false, "last_update_posted_date": "2026-05-04", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 1, "location_summary": "Columbia, South Carolina", "locations": [ { "city": "Columbia", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT07457970" }, { "nct_id": "NCT07224529", "title": "Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Meibomian Gland Dysfunction (MGD)" ], "interventions": [ { "name": "Vevye(Cyclosporine 0.1% Ophthalmic Solution)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 48, "start_date": "2026-06-01", "completion_date": "2027-02-01", "has_results": false, "last_update_posted_date": "2026-06-09", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07224529" }, { "nct_id": "NCT07208279", "title": "Cognitive Vitality Pilot Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aging", "Healthy Aging", "Cognition", "Memory", "Brain" ], "interventions": [ { "name": "Axolt Brain Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Bolero - Flavored Drink Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Arizona State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": null, "sex": "ALL", "summary": "55 Years and older" }, "enrollment_count": 16, "start_date": "2025-09-01", "completion_date": "2026-08-11", "has_results": false, "last_update_posted_date": "2025-10-28", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 1, "location_summary": "West Palm Beach, Florida", "locations": [ { "city": "West Palm Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07208279" }, { "nct_id": "NCT03812146", "title": "Primary Care Treatment Integrating Motivation and Exposure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Stress Disorders, Post-Traumatic", "Alcohol-Related Disorders" ], "interventions": [ { "name": "PC-TIME", "type": "BEHAVIORAL" }, { "name": "PC-TAU", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Syracuse VA Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 63, "start_date": "2019-03-01", "completion_date": "2021-11-23", "has_results": true, "last_update_posted_date": "2022-11-16", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 2, "location_summary": "Buffalo, New York • Syracuse, New York", "locations": [ { "city": "Buffalo", "state": "New York" }, { "city": "Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03812146" }, { "nct_id": "NCT02988596", "title": "Role of Rehabilitation in Concussion Management: A Randomized Controlled Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Concussion, Brain" ], "interventions": [ { "name": "Multidimensional Active Rehabilitation", "type": "OTHER" }, { "name": "Enhanced Graded Exertion", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "13 Years to 99 Years" }, "enrollment_count": 251, "start_date": "2017-01", "completion_date": "2019-08", "has_results": false, "last_update_posted_date": "2021-07-30", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 7, "location_summary": "Durham, North Carolina • Elon, North Carolina • Hillsborough, North Carolina + 4 more", "locations": [ { "city": "Durham", "state": "North Carolina" }, { "city": "Elon", "state": "North Carolina" }, { "city": "Hillsborough", "state": "North Carolina" }, { "city": "Pittsboro", "state": "North Carolina" }, { "city": "Salisbury", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02988596" }, { "nct_id": "NCT00399880", "title": "Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Coronary Syndrome (ACS)" ], "interventions": [ { "name": "Health literacy intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 130, "start_date": "2006-11", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2017-09-25", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00399880" }, { "nct_id": "NCT06835959", "title": "Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension in Pregnancy", "Chronic Hypertension", "Gestational Hypertension" ], "interventions": [ { "name": "Moms@Home", "type": "BEHAVIORAL" }, { "name": "Enhanced Standard of Care", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Massachusetts, Worcester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 100, "start_date": "2025-05-16", "completion_date": "2027-11-16", "has_results": false, "last_update_posted_date": "2026-06-16", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 1, "location_summary": "Worcester, Massachusetts", "locations": [ { "city": "Worcester", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06835959" }, { "nct_id": "NCT04561544", "title": "Pilot Test of a Cultural Intervention to Enhance Alaska Native Students' Behavioral Health", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Depression", "Anxiety", "Suicidal Ideation", "Substance Use" ], "interventions": [ { "name": "Knowing Who You Are (Becoming): Cultural Identity Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Alaska Anchorage", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 44, "start_date": "2020-08-30", "completion_date": "2022-05-31", "has_results": false, "last_update_posted_date": "2023-12-11", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 1, "location_summary": "Anchorage, Alaska", "locations": [ { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT04561544" }, { "nct_id": "NCT04981509", "title": "Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hereditary Leiomyomatosis and Renal Cell Carcinoma", "Papillary Renal Cell Carcinoma", "Renal Cell Carcinoma", "Sporadic Papillary Renal Cell Carcinoma", "Stage III Renal Cell Cancer AJCC v8", "Stage IV Renal Cell Cancer AJCC v8" ], "interventions": [ { "name": "Atezolizumab", "type": "BIOLOGICAL" }, { "name": "Bevacizumab", "type": "BIOLOGICAL" }, { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Scan", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Computed Tomography with Contrast", "type": "PROCEDURE" }, { "name": "Erlotinib", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Sodium Fluoride F-18", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE", "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 65, "start_date": "2022-06-10", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-09-29", "last_synced_at": "2026-10-21T18:04:52.333Z", "location_count": 13, "location_summary": "La Jolla, California • Atlanta, Georgia • Chicago, Illinois + 7 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04981509" } ] }